PGA-SF core-shell scaffold capable of releasing IL-4 and TCP in dual mode, and preparation method and application of PGA-SF core-shell scaffold
Patent Information
- Application Number
- CN202410983314.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-22
- Publication Date
- 2024-11-12
AI Technical Summary
The existing PGA-SF core-shell stents have limited effects in promoting bone regeneration and mineralization, especially in the anti-inflammatory and promoting bone regeneration dynamics.
PGA-SF core-shell electrospinning scaffolds using dual-mode release IL-4 and TCP, and fiber scaffolds are constructed through electrospinning technology, using SF shell-carried interleukin 4 (IL-4) and PGA core-carried tricalcium phosphate (TCP) ), achieve the coordinated release of IL-4 and TCP to regulate inflammatory response and promote bone regeneration.
This scaffold can effectively limit early inflammation, promote macrophage polarization to M2 type, enhance osteogenic differentiation of BMSCs, significantly improve the bone regeneration effect in the body, and provide a microenvironment that is more suitable for bone healing.
Smart Images

Figure CN118924950A_ABST
